Long‐term results of a randomized study comparing parathyroidectomy with cinacalcet for treating tertiary hyperparathyroidism
- 21 May 2020
- journal article
- research article
- Published by Wiley in Clinical Transplantation
- Vol. 34 (8) , e13988
Abstract
Tertiary hyperparathyroidism is a common cause of hypercalcemia after kidney transplantation (KT) and has been associated with renal dysfunction, bone mineral density loss, and increased risk of fracture and cardiovascular events. In a previous 12‐month clinical trial, we demonstrated that subtotal parathyroidectomy was more effective than cinacalcet for controlling hypercalcemia. In the current study, we retrospectively evaluate whether this effect is maintained after 5 years of follow‐up. In total, 24 patients had data available at 5 years, 13 in the cinacalcet group and 11 in the parathyroidectomy group. At 5 years, 7 of 11 patients (64%) in the parathyroidectomy group and 6 of 13 patients (46%) in the cinacalcet group (P = .44) showed normocalcemia. However, recurrence of hypercalcemia was only observed in the cinacalcet group (P = .016). Subtotal parathyroidectomy retained a greater reduction in intact parathyroid hormone (iPTH) compared with cinacalcet group. No differences were observed in kidney function and incidence of fragility fractures between both groups. Cinacalcet was discontinued in 5 out of 13 patients. In conclusion, in kidney transplant patients with tertiary hyperparathyroidism recurrence of hypercalcemia after 5‐year follow‐up is more frequent in cinacalcet than after subtotal parathyroidectomy.Keywords
This publication has 26 references indexed in Scilit:
- Effect of Cinacalcet in Kidney Transplant Patients With HyperparathyroidismTransplantation Proceedings, 2019
- Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it mattersKidney International, 2017
- Systematic review of surgical and medical treatment for tertiary hyperparathyroidismBritish Journal of Surgery, 2017
- A Prospective Cohort Study of Mineral Metabolism After Kidney TransplantationTransplantation, 2016
- Increased Risk of All-Cause Mortality and Renal Graft Loss in Stable Renal Transplant Recipients With HyperparathyroidismTransplantation, 2015
- Persistent Hyperparathyroidism Is a Major Risk Factor for Fractures in the Five Years After Kidney TransplantationAmerican Journal of Transplantation, 2013
- Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney diseaseKidney International, 2011
- Cinacalcet Effectively Reduces Parathyroid Hormone Secretion and Gland Volume Regardless of Pretreatment Gland Size in Patients with Secondary HyperparathyroidismClinical Journal of the American Society of Nephrology, 2010
- Natural history of parathyroid function and calcium metabolism after kidney transplantation: a single-centre studyNephrology Dialysis Transplantation, 2004
- Comparison of Mortality in All Patients on Dialysis, Patients on Dialysis Awaiting Transplantation, and Recipients of a First Cadaveric TransplantNew England Journal of Medicine, 1999